News & Updates

Adaptive vs conventional deep-brain stimulation offers advantages for Parkinson’s disease

06 Oct 2021 by

A small open-label study supports the safety and motor performance effectiveness of closed-loop adaptive deep-brain stimulation (aDBS) compared with conventional daily deep-brain stimulation (cDBS) sessions in Parkinson’s disease (PD) patients.

Adaptive vs conventional deep-brain stimulation offers advantages for Parkinson’s disease

06 Oct 2021

Neural stem cell delivery of oncolytic adenovirus feasible in newly diagnosed malignant glioma

06 Oct 2021 by

A first-in-human, open-label, phase I, dose-escalation trial shows that treatment of newly diagnosed malignant glioma with an engineered oncolytic adenovirus delivered by neural stem cells (NSCs) is feasible and safe.

Neural stem cell delivery of oncolytic adenovirus feasible in newly diagnosed malignant glioma

06 Oct 2021

Thrombectomy a viable first-line therapy for stroke in pregnant women, new mothers

05 Oct 2021 by

In the treatment of women with acute ischaemic stroke, mechanical thrombectomy is effective and can be safely performed during pregnancy or the postpartum period, as shown in a study.

Thrombectomy a viable first-line therapy for stroke in pregnant women, new mothers

05 Oct 2021

Gabapentin may promote abstinence in alcohol use disorder

04 Oct 2021

A recent study shows evidence for a biomarker of efficacious treatment that may be used to assess other glutamatergic or GABAergic medications for alcohol use disorder (AUD) and related conditions, as well as provide insight into the means through which gabapentin may promote abstinence in individuals with AUD.

Gabapentin may promote abstinence in alcohol use disorder

04 Oct 2021

Getting risk factors under control staves off dementia in T2D

02 Oct 2021 by

While people with type 2 diabetes (T2D) have an increased risk of developing dementia, this excess risk can be mitigated by maintaining a healthy lifestyle to keep several risk factors under control, according to a study presented at EASD 2021.

Getting risk factors under control staves off dementia in T2D

02 Oct 2021

Adjusted antiplatelet therapy after stenting beneficial to unruptured intracranial aneurysm patients

02 Oct 2021

Antiplatelet therapy guided by platelet function monitoring helps prevent thromboembolic events among patients with unruptured intracranial aneurysm who have undergone stent placement but at the cost of higher minor or minimal bleeding events, according to data from an open-label study.

Adjusted antiplatelet therapy after stenting beneficial to unruptured intracranial aneurysm patients

02 Oct 2021

Pimavanserin for dementia-related psychosis: to continue or not?

01 Oct 2021 by

In individuals with dementia-related psychosis (DRP) who had a response to the oral 5-HT2A* inverse agonist and antagonist pimavanserin, an atypical antipsychotic agent, the risk of relapse was lower among those who continued the drug vs those who stopped it, the phase III HARMONY trial suggests.

Pimavanserin for dementia-related psychosis: to continue or not?

01 Oct 2021

Blood pressure variability implicated in dementia risk

01 Oct 2021

Individuals with higher blood pressure (BP) variability are at increased risk of developing probable dementia despite good BP control, according to a post hoc analysis of the SPRINT MIND* trial.

Blood pressure variability implicated in dementia risk

01 Oct 2021

Some children in need of neurodevelopmental review after picornavirus CNS infection

30 Sep 2021

A parent-administered assessment of children with a history of early picornavirus infection of the central nervous system (CNS) has identified a subgroup that needs formal neurodevelopmental review, reports a recent study.

Some children in need of neurodevelopmental review after picornavirus CNS infection

30 Sep 2021

Long-term risk of anticoagulant-related bleeding high in patients with first unprovoked VTE

26 Sep 2021

There appears to be substantial long-term risks and consequences of anticoagulant-related major bleeding in patients with a first unprovoked venous thromboembolism (VTE), suggests a recent study.

Long-term risk of anticoagulant-related bleeding high in patients with first unprovoked VTE

26 Sep 2021

News & Updates

Filter by Specialty:

Specialty:

Adaptive vs conventional deep-brain stimulation offers advantages for Parkinson’s disease

Adaptive vs conventional deep-brain stimulation offers advantages for Parkinson’s disease

Neural stem cell delivery of oncolytic adenovirus feasible in newly diagnosed malignant glioma

Neural stem cell delivery of oncolytic adenovirus feasible in newly diagnosed malignant glioma

Thrombectomy a viable first-line therapy for stroke in pregnant women, new mothers

Thrombectomy a viable first-line therapy for stroke in pregnant women, new mothers

Gabapentin may promote abstinence in alcohol use disorder

Gabapentin may promote abstinence in alcohol use disorder

Getting risk factors under control staves off dementia in T2D

Getting risk factors under control staves off dementia in T2D

Adjusted antiplatelet therapy after stenting beneficial to unruptured intracranial aneurysm patients

Adjusted antiplatelet therapy after stenting beneficial to unruptured intracranial aneurysm patients

Pimavanserin for dementia-related psychosis: to continue or not?

Pimavanserin for dementia-related psychosis: to continue or not?

Blood pressure variability implicated in dementia risk

Blood pressure variability implicated in dementia risk

Some children in need of neurodevelopmental review after picornavirus CNS infection

Some children in need of neurodevelopmental review after picornavirus CNS infection

Long-term risk of anticoagulant-related bleeding high in patients with first unprovoked VTE

Long-term risk of anticoagulant-related bleeding high in patients with first unprovoked VTE